These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 11136367)

  • 41. Improvement of spasticity following intermittent theta burst stimulation in multiple sclerosis is associated with modulation of resting-state functional connectivity of the primary motor cortices.
    Boutière C; Rey C; Zaaraoui W; Le Troter A; Rico A; Crespy L; Achard S; Reuter F; Pariollaud F; Wirsich J; Asquinazi P; Confort-Gouny S; Soulier E; Guye M; Pelletier J; Ranjeva JP; Audoin B
    Mult Scler; 2017 May; 23(6):855-863. PubMed ID: 27481208
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Multiple sclerosis. 8. Intrathecal phenol block in spasticity].
    Fagerberg G; Höök O
    Lakartidningen; 1970 Jul; 67(29):3315-7. PubMed ID: 5452191
    [No Abstract]   [Full Text] [Related]  

  • 43. A new multiple sclerosis spasticity treatment option: effect in everyday clinical practice and cost-effectiveness in Germany.
    Flachenecker P
    Expert Rev Neurother; 2013 Feb; 13(3 Suppl 1):15-9. PubMed ID: 23369055
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Treatment with acetazolamide of brain-stem and spinal paroxysmal disturbances in multiple sclerosis.
    Voiculescu V; Pruskauer-Apostol B; Alecu C
    J Neurol Neurosurg Psychiatry; 1975 Feb; 38(2):191-3. PubMed ID: 1151400
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Intrathecal baclofen therapy for the symptomatic treatment of hereditary spastic paraplegia.
    Margetis K; Korfias S; Boutos N; Gatzonis S; Themistocleous M; Siatouni A; Dalivigka Z; Flaskas T; Stranjalis G; Boviatsis E; Sakas D
    Clin Neurol Neurosurg; 2014 Aug; 123():142-5. PubMed ID: 24973568
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Anodal transcranial direct current stimulation of motor cortex does not ameliorate spasticity in multiple sclerosis.
    Iodice R; Dubbioso R; Ruggiero L; Santoro L; Manganelli F
    Restor Neurol Neurosci; 2015; 33(4):487-92. PubMed ID: 26409407
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Efficacy, safety and tolerability of an orally administered cannabis extract in the treatment of spasticity in patients with multiple sclerosis: a randomized, double-blind, placebo-controlled, crossover study.
    Vaney C; Heinzel-Gutenbrunner M; Jobin P; Tschopp F; Gattlen B; Hagen U; Schnelle M; Reif M
    Mult Scler; 2004 Aug; 10(4):417-24. PubMed ID: 15327040
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A case of hypomagnesaemia due to malabsorption, unresponsive to oral administration of magnesium glycerophosphate, but responsive to oral magnesium oxide supplementation.
    Ross JR; Dargan PI; Jones AL; Kostrzewski A
    Gut; 2001 Jun; 48(6):857-8. PubMed ID: 11358909
    [No Abstract]   [Full Text] [Related]  

  • 49. Long-term intrathecal Baclofen infusion in supraspinal spasticity of adulthood.
    Dario A; Di Stefano MG; Grossi A; Casagrande F; Bono G
    Acta Neurol Scand; 2002 Feb; 105(2):83-7. PubMed ID: 11903116
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A double-blind trial with baclofen (Lioresal) and diazepam in spasticity due to multiple sclerosis.
    From A; Heltberg A
    Acta Neurol Scand; 1975 Feb; 51(2):158-66. PubMed ID: 1090103
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Diazepam in the treatment of spasticity. A preliminary quantitative evaluation.
    Evine IM; Jossmann PB; Friend DG; DeAngelis V; Kane M
    J Chronic Dis; 1969 Jun; 22(1):57-62. PubMed ID: 5794241
    [No Abstract]   [Full Text] [Related]  

  • 52. Effectiveness of botulinum toxin A in the treatment of spasticity of the lower extremities in adults - preliminary report.
    Opara J; Hordyńska E; Swoboda A
    Ortop Traumatol Rehabil; 2007; 9(3):277-85. PubMed ID: 17721426
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Epidemiology and clinical assessment of spasticity in multiple sclerosis].
    Bensmail D; Vermersch P
    Rev Neurol (Paris); 2012 Apr; 168 Suppl 3():S45-50. PubMed ID: 22721364
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Intrathecal baclofen for spastic hypertonia from stroke.
    Meythaler JM; Guin-Renfroe S; Brunner RC; Hadley MN
    Stroke; 2001 Sep; 32(9):2099-109. PubMed ID: 11546903
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hemifacial spasm. Occurrence in multiple sclerosis.
    Telischi FF; Grobman LR; Sheremata WA; Apple M; Ayyar R
    Arch Otolaryngol Head Neck Surg; 1991 May; 117(5):554-6. PubMed ID: 1850603
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The effect of baclofen on the transmission in spinal pathways in spastic multiple sclerosis patients.
    Orsnes G; Crone C; Krarup C; Petersen N; Nielsen J
    Clin Neurophysiol; 2000 Aug; 111(8):1372-9. PubMed ID: 10904217
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Botulinum toxin (Dysport) treatment of hip adductor spasticity in multiple sclerosis: a prospective, randomised, double blind, placebo controlled, dose ranging study.
    Hyman N; Barnes M; Bhakta B; Cozens A; Bakheit M; Kreczy-Kleedorfer B; Poewe W; Wissel J; Bain P; Glickman S; Sayer A; Richardson A; Dott C
    J Neurol Neurosurg Psychiatry; 2000 Jun; 68(6):707-12. PubMed ID: 10811692
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Levamisole treatment in multiple sclerosis and spastic pyramidal syndromes].
    Truşcă E; Stoica I
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Neurol Psihiatr Neurochir; 1982; 27(2):125-35. PubMed ID: 6216567
    [No Abstract]   [Full Text] [Related]  

  • 59. [Subarachnoid application of phenol in the treatment of spasm].
    Dogan S; Jusić A
    Neuropsihijatrija; 1963; 11(3):261-8. PubMed ID: 5899911
    [No Abstract]   [Full Text] [Related]  

  • 60. [Intrathecal baclofen in severe spasticity due to multiple sclerosis].
    Sławek J; Zieliński P; Hołub-Kucharska W; Kaniszewska J; Paczkowska M; Słoniewski P
    Neurol Neurochir Pol; 2003; 37(5):1135-42; discussion 1143. PubMed ID: 15174259
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.